5th gen glp-1 Understanding the Next-Gen Weight Loss Drug: Retatrutide (GLP-1, GIP, and Glucagon Receptor Agonist) MEET THE QUINTUPLE AGONIST 5

Three large pharmaceutical makers are jockeying for position in the rapidly expanding market for GLP-1 drugs.

Hims & Hers Health (NYSE:HIMS) is facing a patent infringement lawsuit from Novo Nordisk over its compounded weight loss drugs

Novo Nordisk India chief says GLP-1 adoption remains low and the market untapped despite patent expiry opening it to generics

Pretty much what I said, guess were going to have to wait for more data on whether this issue is actually an issue.

The number of therapeutic options is limited and are often associated with adverse side effects

Cutting-Edge & Next-Generation Akkermansia*: Preloaded with 2 billion TFU of clinically validated akkermansia muciniphila per serving, Vitalitown Akkermansia Muciniphila is designed to boost natural GLP-1 for optimal metabolic health and enhance the gut lining.* The specially-added inulin in our formula helps fuel good critters in your gut and improve digestion & metabolism.*